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Abstract
In the Arabidopsis thaliana genome, over 1000 putative genes encoding small, presumably secreted, signalling pep-
tides can be recognized. However, a major obstacle in identifying the function of genes encoding small signalling pep-
tides is the limited number of available loss-of-function mutants. To overcome this, a promising new tool, antagonistic 
peptide technology, was recently developed. Here, this antagonistic peptide technology was tested on selected CLE 
peptides and the related IDA peptide and its usefulness in the context of studies of peptide function discussed. Based 
on the analyses, it was concluded that the antagonistic peptide approach is not the ultimate means to overcome 
redundancy or lack of loss-of-function lines. However, information collected using antagonistic peptide approaches 
(in the broad sense) can be very useful, but these approaches do not work in all cases and require a deep insight on 
the interaction between the ligand and its receptor to be successful. This, as well as peptide ligand structure consid-
erations, should be taken into account before ordering a wide range of synthetic peptide variants and/or generating 
transgenic plants.
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Introduction
Small signalling peptides are able to elicit a vast array of biologi-
cal and physiological responses, allowing the plant to develop and 
adapt to changes in the surrounding environment (Czyzewicz 
et  al., 2013; Murphy et  al., 2012). In the Arabidopsis thaliana 
genome, over 1000 putative genes encoding small, presumably 
secreted, signalling peptides can be recognized (Lease and Walker, 
2006). These small signalling peptides are mainly perceived 
by receptors, such as receptor kinases, and in the A.  thaliana 
genome, over 600 genes encoding putative receptor-like kinase 
(RLK) proteins have been detected (Shiu and Bleecker, 2001a, 
b). However, to date, only a small portion of these putative small 
signalling peptides have been functionally characterized and few 
have been linked to a receptor (Butenko et al., 2009; Czyzewicz 
et al., 2013; Lee and Torii, 2012; Murphy et al., 2012).
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Small signalling peptides consist of usually <20 amino 
acids in their mature form and rarely >120 amino acids as a 
full-length precursor. Although there are hardly any data for 
most small signalling peptides, they are likely often present 
at very low (nanomolar range) physiological concentrations. 
Forward and reverse genetic approaches have been employed 
to study the biological function of genes encoding small sig-
nalling peptides. For example, CLAVATA3 (CLV3), a peptide 
regulating maintenance of plant stem cells, was identified in 
a forward genetic screen (Clark et al., 1995; Fletcher et al., 
1999). The clv3 mutants have an enlarged shoot apical mer-
istem (SAM) and floral meristems, which generate supernu-
merary floral organs, suggesting a general role in regulating 
above-ground meristematic growth (Clark et al., 1996). CLV3 
belongs to the family of CLV3/EMBRYO SURROUNDING 
REGION-related (CLE) peptides, which consists of 31 mem-
bers in A. thaliana. These peptides share a conserved 12–14 
amino acid C-terminal domain that is proteolytically released 
and has been shown to function in various contexts, including 
shoot and root meristem development, nodulation, embryo 
and endosperm development, regulation of root architecture 
in response to nutrients, and vascular development (Araya 
et al., 2014; Cock and McCormick, 2001; Fiers et al., 2005; 
Fiume and Fletcher, 2012; Hirakawa et al., 2008; Hobe et al., 
2003; Jun et al., 2010; Lim et al., 2011; Mortier et al., 2010; 
Okamoto et al., 2013; Reid et al., 2011; Stahl et al., 2009). 
Genetic interaction studies suggested CLV3 to act as a small 
signalling peptide since mutations in the RLK encoding 
gene, CLV1, had a similar phenotype to clv3 mutants and 
the overexpression phenotype of CLV3 was lost in the clv1 
mutant background (Brand et al., 2000). Indeed, the identi-
fication of the mature active CLV3 peptide and biochemical 
evidence for its interaction with CLV1 was confirmed almost 
a decade later (Ogawa et al., 2008; Ohyama et al., 2009). This 
example illustrates some of the difficulties in identifying the 
mature active form of small signalling peptides in plants and 
thereafter finding their receptors and/or interacting signalling 
partners.
One major obstacle in identifying the function of genes 
encoding small signalling peptides is the limited number of 
available loss-of-function mutants, since most have no use-
ful T-DNA insertions, partly because small genes are less 
likely to be targeted by a T-DNA insertion. To complicate 
matters further, the functional redundancy of some small 
signalling peptides and RLKs can mask phenotypes when 
only one family member is successfully disrupted. Although 
some small signalling peptides have been discovered through 
screening of T-DNA or transposon insertion mutants—such 
as INFLORESECENCE DEFICIENT IN ABSCISSION 
(IDA), TAPETUM DETERMINANT1 (TPD1), CLV3, 
and CLE40 (Butenko et al., 2003; Fletcher et al., 1999; Hobe 
et al., 2003; Yang et al., 2003), new approaches and technolo-
gies are required to facilitate the functional analyses of genes 
encoding small signalling peptides and their putative corre-
sponding receptor partners (Butenko et al., 2014; Stes et al., 
2015).
To interfere with and unravel endogenous peptide func-
tion, antagonistic peptides—such as mutant peptide variants, 
chemically modified peptides or peptide-like molecules that 
can affect peptide ligand–receptor (kinase) pathways are an 
important tool. In this context, structure-function/activity 
analyses can provide useful information on peptide residues 
critical for function. With respect to CLE peptides, such analy-
ses were used to test, for example, suppression of nodulation 
capability in soybean (Glycine max) roots of the nodulation-
controlling RHIZOBIA-INDUCED CLE1 (GmRIC1) (Reid 
et al., 2013) or regulation of primary and lateral root growth 
of various CLE peptides (Czyzewicz et al., 2015; Kondo et al., 
2008). Recently, this approach was used to develop a promis-
ing new tool, referred to as antagonistic peptide technology, 
for functional dissection of CLE peptides (Song et al., 2013). 
Based on transgenic plants carrying CLV3 variants where 
each of the 12 residues in the core CLE motif were one by 
one replaced by alanine (Ala), it was shown that the glycine 
(Gly) to Ala substitution at position six gave a weak clv3 phe-
notype. Subsequently, replacing this highly conserved Gly resi-
due with other amino acids revealed that a Gly to threonine 
(Thr) produced a phenotype most similar to clv3 mutants. 
This was further tested using synthetic CLV3 peptide with 
the Gly to Thr substitution (CLV3p6Thr), which was also able 
to produce—although less effective—the clv3 mutant pheno-
type, and which could compete with wild-type synthetic CLV3 
peptide (CLV3p). These exciting observations suggested that 
the CLV3p6Thr variant could act as an antagonistic peptide. 
Specifically, a loss-of-function phenotype is suggested to be 
obtained through competitive inhibition, namely the peptide is 
proposed to be able to bind to the native receptor, but unable to 
activate it, since a functionally critical amino acid is mutated. 
Probably the CLV3p6Thr variant has compromised peptide 
flexibility leading to stronger interaction with corresponding 
receptors and to disrupted downstream signal transduction. 
Taken together, such antagonistic peptides would provide a 
powerful tool for the functional dissection of CLEs in plants, 
and might also have the potential to be used for other plant 
peptides. Based on this assumption and the conserved nature 
of the Gly at position six (Fig. 1), this technology was applied 
to CLE8 (giving rise to embryo-lethal phenotype) and CLE22 
(giving rise to short root phenotype) (Song et al., 2013).
Here, this antagonistic peptide technology was tested, spe-
cifically Gly6-to-Ala or Gly6-to-Thr, as used by Song et  al. 
(2013), on selected CLE peptides and the related IDA pep-
tide, and its usefulness discussed in the context of studies of 
peptide function.
Materials and methods
Plant growth conditions
For the work on CLE40 and CLV3, seeds were surface sterilized 
with chlorine gas and imbibed in 0.1% (w/v) agarose for 2 d at 4 °C 
before being plated onto 0.5× Murashige and Skoog (MS) medium 
with Gamborgs No. 5 vitamins (Duchefa), 0.5 g/l 2-(N-morpholino)
ethanesulfonic acid (MES), 1% (w/v) sucrose, and 1.2% (w/v) plant 
agar. Plates were incubated vertically in a growth chamber with con-
stant light at 21 °C for 5 d. For peptide-containing plates, synthetic 
dodecapeptides were added to a final concentration of 1 µM. For 
the work on CLE1/4, CLE7, CLE26, and CLE27, seeds were sur-
face sterilized by immersion in 70% ethanol for 30 s, and incubated 
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in 20% bleach at room temperature for 20 min. Sterile seeds were 
vernalized in water at 4 °C for 2 d, before being plated onto 0.5× MS 
medium supplemented with 0.1 g/l Myo-inositol (Sigma Aldrich), 
0.5 g/l MES (Sigma Aldrich), and 1% (w/v) bacteriological agar. 
Plants were incubated vertically under constant light at 21 °C until 
12 d after germination. Synthetic CLE was added to a final con-
centration of 10 µM or 10 nM. The work on CLE45 was essentially 
performed as previously described (Rodriguez-Villalon et al., 2014).
Starch staining
Starch granules and cell walls in root tips were stained with the 
mPSPI method and imaged with a confocal microscope as previ-
ously described (Truernit et al., 2008).
Oxidative burst experiments
For transient expression, Agrobacterium tumefaciens carrying 
HAESA-LIKE 2 (HSL2) in frame with eGFP in an estradiol-
inducible expression vector described previously (Bleckmann et al., 
2010), was infiltrated into Nicotiana benthamiana leaves according 
to (Mueller et al., 2012). The oxidative burst experiment was per-
formed as previously described by (Butenko et al., 2014), with the 
exception that 3 d after infiltration with A. tumefaciens, leaf pieces 
of N. benthamiana were induced with 20 μM estradiol before cut. 
Light emission was measured in a Wallac 1420 VICTOR2™ micro-
plate luminometer (PerkinElmer).
Peptide structure predictions
The recently published solution structure of CLE10p, solved using 
nuclear magnetic resonance (NMR) (MMDB ID: 125940; PMBID: 
2MD), depicts the backbone of the PXGP core (position 4–7) as 
a smooth curve protruding from the rest of the peptide. To inves-
tigate the effect of mutations in this core of the peptides investi-
gated, amino acid sequences with the structure AAA[core]AAA 
with the core PGGP, PGAP, PGTP, PRGP, PRTP, PSAP, or PSTP 
were submitted for analysis in PEP-FOLD (http://mobyle.rpbs.univ-
paris-diderot.fr/cgi-bin/portal.py?form=PEP-FOLD#forms::PEP-
FOLD) using standard settings.
Results and discussion
‘Antagonistic’ CLE peptides
Among many processes (Cock and McCormick, 2001; Fiume 
and Fletcher, 2012; Hirakawa et  al., 2008; Okamoto et  al., 
2013), various CLE peptides affect primary and lateral root 
growth and development (Czyzewicz et  al., 2015; Depuydt 
et al., 2013; Fiers et al., 2005; Hobe et al., 2003; Jun et al., 2010; 
Rodriguez-Villalon et  al., 2014; Rodriguez-Villalon et  al., 
2015; Stahl et al., 2009). To build on previous work investigat-
ing CLE peptides in the context of lateral root development, 
primary root growth, root apical stem cell maintenance, and 
vascular development, putative antagonistic versions of 
CLV3, CLE1/4, CLE7, CLE26, CLE27, CLE40, and CLE45 
peptides were designed—based on the findings by Song et al. 
(2013)—to further unravel CLE peptide function (Figs 2A, 
3A, 4A). To assess the function of these mutated chemically 
synthesized CLE peptides with Gly/cysteine (Cys) to Ala 
or Gly/Cys to Thr substitutions (referred to as mCLEpAla6 
or mCLEp6Thr, respectively), a number of biological assays 
were used.
The antagonistic peptide technology was first applied to 
CLE45 peptide (CLE45p), which, when applied exogenously, 
leads to shorter primary roots because it suppresses pro-
tophloem differentiation (Depuydt et  al., 2013; Rodriguez-
Villalon et al., 2014). To explore a potential loss-of-function 
phenotype, synthetic mCLE45p6Thr peptide was applied and 
its effect on primary root development upon external appli-
cation evaluated (Fig. 2A, B). This revealed that at the low 
nanomolar range mCLE45p6Thr does not have an effect on 
primary root length as compared with the wild-type CLE45p 
(Fig. 2B), again confirming that position six is important for 
peptide activity. However, a higher concentration of 1 μM 
mCLE45p6Thr had the same effect as the unmodified wild-type 
CLE45p (Fig. 2B). In addition, this peptide was not able to 
out-compete the effects of simultaneous CLE45p application 
(Fig. 2B). Thus, while the mCLE45p6Thr peptide does not act 
as an antagonistic peptide, a CLE45p variant was obtained, 
which has identical effects as the wild-type version but required 
application of higher peptide concentrations. The notion that 
mCLE45p6Thr is a weak CLE45p, rather than an antago-
nistic version, was confirmed in planta (Rodriguez-Villalon 
et al., 2014). Plants that express a wild-type pCLE45::CLE45 
transgene are notoriously difficult to create, presumably 
because of the detrimental effects of increased CLE45 dosage. 
However, the few lines that were eventually obtained recapit-
ulated the root phenotype observed upon external CLE45p 
application (Fig. 2C). Specifically, in pCLE45::CLE45 lines, 
root growth was impaired, the periclinal division of the sieve 
element precursor cell was frequently abolished, and pro-
tophloem differentiation was often suppressed (Fig.  2D). 
This phenotype is similar to plants that express a correspond-
ing pCLE45::CLE456Thr transgene, which are much easier to 
obtain (Rodriguez-Villalon et  al., 2014). Thus, the data for 
both tissue culture assay and in planta are consistent with the 
interpretation that mCLE45p6Thr is a weak rather than an 
antagonistic version of the CLE45 peptide.
Next, the antagonistic peptide approach for CLE40 was 
explored (Fig. 3A). It was previously shown that an increas-
ing concentration of synthetic CLE40 peptide reduces 
stemness and causes differentiation of columella stem cells 
(CSCs), quiescent centre (QC) cells, and proximal initial 
(P1) cells in wild-type roots (Fig. 3B, D, H, Supplementary 
Table S1 available at JXB online) (Stahl et  al., 2013). Also 
Fig. 1. Alignment of CLE peptides used in Song et al. (2013). Conserved 
glycine (G) at position six is indicated with a blue arrowhead. (This figure is 
available in colour at JXB online.)
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synthetic CLV3 peptide acts similarly on the stemness in the 
root tip (Fig.  3E, G, Supplementary Table S1 available at 
JXB online). In contrast, in the shorter cle40 mutant roots, 
differentiation of CSC daughters into CCs was significantly 
delayed (Fig. 3B, F, H, Supplementary Table S1 available at 
JXB online) (Hobe et al., 2003; Stahl et al., 2009). Wild-type 
roots carry mostly one (at D1 position) or, after a recent cell 
division, two layers of CSCs distal to the QC (at D1 and D2 
positions), which lack stainable starch granules (Fig. 3B, H, 
Supplementary Table S1). In cle40 root tips, additional CSCs 
in more distal positions (D2) were found (Fig.  3B, C, H, 
Supplementary Table S1). To assess if  synthetic mCLE40p6Thr 
and mCLV3p6Thr variants could be used as antagonistic pep-
tides to obtain a loss-of-function phenotype, their impact on 
the distal root stemness was evaluated (Fig. 3A). This revealed 
a response comparable with the wild-type CLE40p or CLV3p 
treatments (Fig. 3E, G, H, Supplementary Table S1 available 
at JXB online). Taken together, this suggests that the Gly to 
Thr substitution in CLE40 and CLV3 does not give rise to an 
antagonistic peptide.
Finally, while treatment of A. thaliana seedlings with 10 µM 
wild-type CLE1/4p, CLE7p, CLE26p, and CLE27p resulted 
in a short primary root and more lateral roots (Fig. 4B, C) 
(Czyzewicz et al., 2015; Depuydt et al., 2013; Kinoshita et al., 
2007; Rodriguez-Villalon et  al., 2014), this does not neces-
sarily reflect their natural function. However, based on the 
CLE1/4, CLE7, CLE26, and CLE27 expression patterns, a 
role in lateral root development might be expected (Czyzewicz 
et al., 2015; Jun et al., 2010). In this context, only CLE26p 
gave rise to a short primary root and increased lateral root 
density at a concentration of 10 nM (Fig.  4B) (Czyzewicz 
et al., 2015; Rodriguez-Villalon et al., 2015), further support-
ing caution when interpreting exogenous peptide application 
results, especially at higher concentrations. To assess if  the 
above-mentioned CLE peptides have a role in primary and 
lateral root development, the antagonistic peptide technology 
was attempted (Fig. 4A). However, analysis of mutated chem-
ically synthesized CLE peptides (mCLEp) at 10 μM revealed 
that, although mCLE1/4p6Ala/Thr and mCLE7p6Ala/Thr did not 
induce a primary root shortening or a lateral root density 
increase—unlike the non-mutated forms of these peptides, 
mCLE1/4p6Thr and mCLE7p6Ala/Thr were also unable to pro-
duce an obvious dominant negative root phenotype, namely 
an expected longer primary root and/or decrease in lateral 
root density (Fig. 4B, C). However, for mCLE1/4p6Ala, a sub-
tle increase in primary root length, but no effect on lateral root 
density was observed (Fig. 1C). It should be pointed out that 
since the receptor, and the associated loss-of-function pheno-
type, for these peptides is not known, the expected dominant 
negative root phenotype remains speculative. Nevertheless, 
this outcome suggested that for CLE1p, CLE4p, and CLE7p 
activity, the Gly at position six is essential, but that this mutant 
form did not appear to act as an antagonistic peptide. In con-
trast, mCLE26p6Ala/Thr and mCLE27p6Ala/Thr displayed a simi-
lar phenotype to the non-mutated forms, namely a significant 
reduction in primary root length (92–95%) and increased lat-
eral root density (110–151%) (Fig. 4B, C), suggesting that the 
sixth amino acid in their respective sequences is not critical 
Fig. 2. CLE45 peptide treatment and pCLE45::CLE45 transgenic lines. 
(A) Sequence of synthetic CLE45 and mCLE45 peptides used. (B) Primary 
root length following treatment of wild-type seedlings with indicated 
concentrations of CLE45p or mCLE45p6Thr. The bar graph indicates the 
mean ± standard error. Statistical significance (Student’s t-test) compared 
with mock is indicated for each time point (DAG, days after germination): 
* P <0.01. (C) Primary root length of pCLE45::CLE45 lines. The bar graph 
indicates the mean ± standard error. Statistical significance (Student’s 
t-test) compared with Col-0 is indicated: * P <0.01. (D) Confocal images 
of primary root meristems of 7-d-old seedlings (propidium iodide-stained; 
composite images). The asterisks highlight the two protophloem strands 
that can be distinguished in wild-type (Col-0) grown on mock (left), but 
that do not develop when grown on 10 nM CLE45p (middle). Protophloem 
strands also do not develop in wild-type seedlings that express a 
pCLE45::CLE45 transgene (right). Scale bar, 100 µm.
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to their function, and also, did not appear to give rise to an 
antagonistic peptide when mutated. Intriguingly, at 10 nM, 
mCLE26p6Ala/Thr retained activity, but was less potent than 
CLE26p. This suggests that mCLE26p6Ala/Thr is a weak rather 
than an antagonistic version of the CLE26 peptide, which is 
in agreement with the results on CLE45. In contrast, most 
Fig. 3. Distal root phenotypes after antagonistic peptide treatments. (A) Sequence of synthetic CLE and mCLE peptides used. (B–H) Distal root cell fates 
were analysed by mPSPI staining 5 d after germination in wild-type (Col-0) and cle40-2 mutant roots (C, D). Representative examples of Col-0 roots 
grown on media with 1 µM CLE40p (E), mCLE40p6Thr (F), CLV3p (G), and mCLV3p6Thr (H) are shown. Frequency of roots carrying starch granules in the 
designated domains is shown in (B). Arrowheads: blue, QC position; yellow, CSC position (D1); red, CC position (D2). Double yellow arrowheads indicate 
CSC fate in D2, whereas the lack of a yellow arrowhead indicates CC fate in D1 position. QC, quiescent centre position; D1, distal layer position one; D2, 
distal layer position two; CC, columella cell position. Scale bars represent 15 µm.
Fig. 4. CLE1/4, CLE7, CLE26, and CLE27 peptide treatment. (A) Sequence of synthetic CLE and mCLE peptides used. (B–E) Treatment of wild-type 
seedlings with 10 µM (B, C) or 10 nM of CLE or mCLE peptide (D, E). Quantification of primary root length (B, D) and emerged lateral root density (C, E) 
for CLEp and mCLEp-treated wild-type seedlings. The bar graph indicates the mean ± standard error. Statistical significance (Student’s t-test) compared 
with no peptide (*) and to CLEp treatment (♦) is indicated: ***/♦♦♦, P <0.001, */♦, P <0.05. (This figure is available in colour at JXB online.)
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mCLE1/4p, mCLE7p, and mCLE27p variants had no altered 
activity compared with the wild-type variant at 10 nM, except 
mCLE1/4p6Ala (Fig. 4D, E). In general, it appears that also 
for CLE1/4p, CLE7p, CLE26p, and CLE27p, the antagonis-
tic peptide technology is not easily applicable.
In conclusion, other amino acid mutations are likely 
required to give rise to (strong) antagonistic CLE1p, CLE4p, 
CLE7p, CLE26p, CLE27p, CLE40p, and CLE45p peptides, 
or alternatively, this approach cannot be universally applied 
with respect to synthetic CLE peptides. A poor effect of syn-
thetic antagonistic peptides could be due to delivery to rel-
evant tissues and/or instability. However, synthetic peptide 
stability issues were not observed in these assays or with 
respect to synthetic control peptides, nor was a lack of phe-
notypes observed when synthetic (antagonistic) peptides 
were exogenously applied to the root. While the latter can be 
a non-specific effect in some cases, specific and local pheno-
types were also observed.
‘Antagonistic’ IDA peptides
In addition, the extent the antagonistic peptide technology 
can be applied to other small signalling peptides was assessed. 
For this, the IDA and IDA-LIKE (IDL) family were cho-
sen, given their sequence similarity to CLEs (Stenvik et al., 
2006). The IDA and IDL1 peptides of 12 amino acids share 
a common core at positions four to seven [PS(G/A)P] and the 
C-terminal end [H(N/H)] with CLV3 and some CLE peptides 
(Figs 5A, 6A). Like CLV3, hydroxylation of the Pro at posi-
tion seven of the IDA dodecapeptide (IDAp, also referred to 
as PIPPo) increases the activity of the peptide (Butenko et al., 
2014). An oxidative burst response in Nicotiana benthamiana 
can be employed as readout for the RLK HAESA-LIKE2 
(HSL2) activation by exogenously applied synthetic IDA pep-
tides (Butenko et  al., 2014). Previous results indicated that 
IDAp binds to HSL2 with a Kd of 20 nM (Butenko et  al., 
2014). As the wild-type IDA peptide has an Ala at position 
six corresponding to the Gly at that position in CLV3, and the 
ida mutant phenotype can be fully rescued by IDL1, which 
has a Gly at this position (Stenvik et al., 2008) (Fig. 6A); both 
of these small amino acids are evidently compatible with high 
signalling activity. It was, however, conceivable that substi-
tution to the larger Thr (mIDAp6Thr) (Fig.  5A) could have 
an effect on receptor binding and/or activation. Therefore, 
the activity of mIDAp6Thr in comparison with the activity 
of synthetic IDAp was assessed in an oxidative burst assay. 
For all peptide concentrations tested, mIDAp6Thr gave the 
same response as IDAp in the presence of its receptor HSL2 
(Fig.  5B), indicating that the mutated peptide was just as 
active as its wild-type counterpart. In conclusion, this muta-
tion neither produced a ligand with weaker activity, nor a 
peptide with antagonistic effect.
Conclusion
Information collected using antagonistic peptide approaches 
(in the broad sense) can be very useful, but these approaches 
do not work in all cases and require a deep insight on the 
interaction between the ligand and its receptor to be success-
ful. While the antagonistic peptide approach might work in a 
number of cases, as described by Song et al. (2013) and Xu 
et al. (2015), its universal applicability remains to be deter-
mined. Initial data were presented for CLV3, CLE8, and 
CLE22, and recently for CLE19 but in the absence of the 
pertinent wild-type control transgenes and genetic knock-
out lines, it remains difficult to judge whether the pheno-
types triggered by mCLE86Thr, mCLE196Thr, and mCLE226Thr 
transgenes are antagonistic or not. Importantly, in view of 
the results presented here, and in agreement with the results 
of Song et al. (2013), it appears that the antagonistic peptide 
technology cannot be easily applied to synthetic CLE peptides 
and—at least—requires expressing mutant variants to deliver 
dominant peptides to their endogenous locations. However, 
as was shown with the CLE456Thr transgene, the latter also 
does not always work. Nevertheless, it can provide novel 
insight that can lead to other tools to dissect peptide activ-
ity, as— for example—the weakened activity of mCLE456Thr 
could be used to functionally characterize CLE45. In addi-
tion, it also does not appear to be straightforward to trans-
late this approach to other peptide families, as exemplified 
Fig. 5. IDA peptide treatment. (A) Sequence of synthetic IDA peptides 
used. (B) N. benthamiana leaf pieces expressing HSL2 were exposed to 
various concentrations of peptides as indicated. Oxidative burst by the 
luminol-based assay was monitored over time as relative light units (RLU). 
Leaf pieces infiltrated with Agrobacterium without HSL2 were exposed to 
1 μM of both peptides and used as control. Error bars indicate standard 
error of n=3 or 4 replicates.
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through analyses on IDA. In general, it was observed that 
whether the mutations have an effect or not, seems dependent 
on the context, with differential sensitivity to conformational 
changes (Fig.  6A and Supplementary Table S2 available at 
JXB online). CLE1/4p and CLE7p are highly similar pep-
tides with the same PGGP core at position four to seven, and 
both lose activity when the Gly at position six is mutated to 
Ala or Thr. Structure prediction for the peptides may suggest 
that a mutation in this context, with the small Gly at posi-
tion five, easily changes the peptide conformation (Fig. 6B). 
Alternatively, all size increases in the side chain of the amino 
acid at position six could interfere with binding of the puta-
tive receptor(s) of CLE1, CLE4, and CLE7. CLE26p and 
CLE45p both have an Arg in the core sequence (PRGP and 
RRGS, respectively) and react similarly to the introduced 
mutations, namely weaker activity when the Gly at position 
six is mutated. The long side chain of Arg might change direc-
tion in the mutant peptides, which might reduce its binding 
affinity for a receptor (Fig. 6C). In contrast, mutation of Ala 
at position six to Thr did not reduce the activity of the IDA 
peptide, which has a PSAP core, suggesting that the serine 
(Ser) residue might stabilize the peptide structure (Fig. 6D).
In conclusion, the antagonistic peptide approach can be a 
useful tool to study the function of some CLE genes (Song 
et  al., 2013; Xu et  al., 2015), but not the ultimate means 
to overcome redundancy or lack of loss-of-function lines 
(Rodriguez-Villalon et al., 2014; this study). However, while 
the approach described by Song et al. (2013), when applied to 
synthetic CLE peptide variants, did not work—for the pep-
tides selected in this study and with respect to the phenotypes 
investigated, it does not preclude there being any other substi-
tution, modification, or combination thereof or a transgene 
that may induce the desired effects. This, as well as structure 
considerations, should be taken into account before ordering 
a wide range of synthetic peptide variants and/or generating 
transgenic plants.
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